A Canvas of Contemporary Insights into Clinical Vitiligo

Document Type

Article

Publication Date

1-1-2025

Publication Title

Dermatologic clinics

Abstract

Vitiligo is a chronic skin condition characterized by the loss of melanocytes, resulting in white patches on the skin. While its exact cause is unknown, it's believed to be an autoimmune disorder involving genetic, environmental, and immunologic factors. Various treatments, including topical drugs, phototherapy, and surgery, exist, but further research is needed for more targeted therapies. Standardization of treatment goals and outcome measures is crucial. Future directions involve personalized treatments based on genetic and immunologic profiles, along with advancements in melanocyte biology for more effective therapies. Collaborative research is the key to improving outcomes and quality of life for vitiligo patients.

Medical Subject Headings

Vitiligo; Humans; Phototherapy; Dermatologic Agents; Melanocytes

PubMed ID

39542565

Volume

43

Issue

1

First Page

67

Last Page

76

Share

COinS